NJTC Investment Fund, L.P., 10% Owner at Cytosorbents Corp (CTSO), sold 2,494,500 shares at $6.01 ($428K) on 2014-08-26, disclosed to the SEC on 2016-01-13.
Open-market sale of $428k CTSO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.01 | 40,000 | $240K | 56.2% |
| 2 | $6.10 | 14,400 | $88K | 20.5% |
| 3 | $5.90 | 8,576 | $51K | 11.8% |
| 4 | $6.00 | 4,000 | $24K | 5.6% |
| 5 | $6.00 | 1,000 | $6K | 1.4% |
| 6 | $6.00 | 218 |
| $1K |
| 0.3% |
| 7 | $6.00 | 704 | $4K | 1.0% |
| 8 | $0.24 | 41,331 | $10K | 2.3% |
| 9 | $0.24 | 8,300 | $2K | 0.5% |
| 10 | $0.24 | 5,752 | $1K | 0.3% |
| 11 | $0.00 | 1,250,000 | $0 | 0.0% |
| 12 | $0.00 | 1,120,219 | $0 | 0.0% |
| Total | $0.17 avg | 2,494,500 | $428K | 100% |